Clinical trial
Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in…
NCT00421096 · Centre Oscar Lambret, Other · Terminated
Key facts
| NCT number | NCT00421096 |
|---|---|
| Title | Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer |
| Official title | Stage IB2 to IVA Uterine Cervical Cancer: Phase 2 Study to Assess a New Therapeutic Sequence Associating a Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine |
| Acronym | GEMCOL |
| Lead sponsor | Centre Oscar Lambret, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Cervical Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Gemcitabine, Radiotherapy, Cisplatin |
| Enrollment | 19 |
| Start date | May 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2011 |
| First posted | Jan 11, 2007 |
| Last update posted | Jul 24, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: